Anesthesia Patient Safety Foundation
search APSF.org:
donate/sponsor
apsf homeapsf home about apsf donorsinitiativesresource centergrantsnews & eventscontact us
   
 
about apsf
Board of Directors
Committees
Foundation History
Pioneering Safety
Statement on Industry Relations
 

APSF History Overview

 
Print this page
Send to a friend
Request information
More information about our newsletter

APSF History

Silker, E.S., Past Executive Director, Anesthesia Patient Safety Foundation

Here, in the year 2001, APSF has enjoyed seventeen years of successful activity in the cause of anesthesia patient safety. Its roots have a basis in history and its dedication to and interest in anesthetic morbidity and mortality has not been the private preserve of the anesthesiologist. While England's John Snow is remembered for his classical study [1] of chloroform deaths, the literature is replete with the names of prominent figures in medicine who wrote about anesthesia but were not anaesthetists. Harvey Cushing [2], then a second year medical student, lost a patient who aspirated gastric contents during an ether anesthetic. He later wrote that this event almost caused him to leave medical school. His classmate, Avery Codman, also a surgeon, fared little better. In a letter dated February 9, 1920, to Cushing, he wrote:

"There was a reason for not publishing a paper entitled, Etherization, in which I describe the process as we then knew it. I recall that the reason for not publishing it was because it described in detail the case which I lost in the OR because I was paying attention to some Tom foolery which you, who had come in from the theatre, were entertaining us with while the poor devil was inhaling vomitus."

Distraction, obviously, is nothing new and it seems appropriate that the word, "vigilance", should occupy the conspicuous center on the seal of the American Society of Anesthesiologists.

Anesthesiologists the world over have long been concerned with and involved in studies related to anesthesia safety. Many prominent anesthesiologists in the United States began to collect statistics of anesthetic morbidity and mortality as early as the 1930's. Even before our preoccupation with the issue of malpractice and its legal implications, data were hard to come by and the various study commissions were largely a repository of anecdotal events.

In 1983, the Royal Society of Medicine of England and the Harvard Medical School jointly sponsored a symposium on anesthesia contributory morbidity and mortality. Forty participants from around the English speaking world were invited to this meeting that was held at the Massachusetts General Hospital. The presenters discussed the morphology and teleology of anesthetic accidents. The principal result of the meeting was an agreement to share statistics and to define the parameters of future studies[3].

One year later, at the 1984 meeting of the American Society of Anesthesiologists, Dr. Ellison C.Pierce, the Society's President, inaugurated the Anesthesia Patient Safety Foundation (APSF). The idea for a patient-centered safety foundation was presented to, and approved by, the ASA House of Delegates during Jeep Pierce's year as President. Its goals were clearly stated:

"The mission of this corporation is to assure that no patient shall be harmed by the effects of anesthesia. The purposes of this corporation are: to foster investigations that will provide a better understanding of preventable anesthetic injuries; encourage programs that will reduce the number of anesthetic injuries; and promote national and international communication of information and ideas about the causes and prevention of anesthetic morbidity and mortality."

A cardinal goal of APSF is to communicate and to disseminate information about issues of anesthesia safety. The APSF Newsletter, published quarterly, has a readership of over 60,000. In addition to anesthesiologists and nurse anesthetists, the distribution includes the nation's risk managers, the Board of Governors of the American College of Surgeons, the liability insurance industry, pharmaceutical companies, medical device manufacturers, the Joint Commission, the FDA, and, far from least, congressional staffers responsible for health care information. In addition to the Newsletter, APSF's website (www.apsf.org) accesses all issues of the Newsletter information as well as information about APSF's other activities.

Stories reported in the Newletter are far ranging. They have included models for risk analysis, the impact of the European work station design on anesthesia practice in the United States, controversies such as FDA's initial attempt to limit the use of succinylcholine in male children, sources of medical gas contamination, the FDA approved Anesthesia Checklist, and most recently, the dangers faced by patients who undergo anesthetics in the private offices of physicians. The number of "letters to the editor" has increased almost exponentially during the past five years.

A second area of uniqueness is the research grant program. Again, the APSF goal states: "To foster investigations that will provide a better understanding of preventable anesthetic injuries." APSF promotes research in anesthesia safety by awarding four or five grants of up to $65,000 per year. Each Winter Edition of the Newsletter reports the awardees and the titles of their research projects. Other areas of study supported by research grants have included the effect of fatigue on resident performance, intra-operative carbon monoxide levels, cerebral ischemia thresholds, and factors affecting intra-operative vigilance. To date, APSF has awarded almost two million dollars in support of such research. One of the most successful projects begun with the help of this grant program has been the development, and ultimate commercial availability, of anesthesia simulators.

Other APSF projects have included recovery room safety issues, the effects of fatigue on acuity, and joint ventures with corporate partners that have resulted in educational brochures for: the prevention of bacterial contamination in anesthetic agents (Zeneca); dosage of agents and essential monitoring for the safe practice of intravenous sedation and analgesia (Roche). APSF has also sponsored the production of three texts: Safety and Cost Containment in Anesthesia, Capnography in Clinical Practice and an indexed compendium of the scientific articles which have appeared in the first eight years of the Newsletter (Little Brown).

APSF is gratified by the recognition it has received in the Institute of Medicine's report entitled, "To Err is Human," which recognizes APSF's leadership in the cause of patient safety. Further, The Agency for Health Care Research and Quality (ARHQ) has enlisted APSF's assistance in developing a National Center for Patient Safety. APSF recognizes that there is still much work to be done, and looks forward to continuing its programs on behalf of all patients who require perioperative care.

 

 
 
 

APSF | Building One, Suite Two | 8007 South Meridian Street
Indianapolis, IN 46217-2922 | f. 317.888.1482
e. walker@apsf.org

Last updated: 02.07.2008

Copyright © 2008. Anesthesia Patient Safety Foundation. All rights reserved.